Trial | Setting | No. of patients (% male) | Age, yr, mean | Disease severity scores, mean | Enrolment criteria | Oxygen therapy protocol, mean ± SD | |
---|---|---|---|---|---|---|---|
HFNC group | Control group | ||||||
Frat et al., 2015 (19) | 23 ICUs in France and Belgium | 310 (68.4) |
| SAPS II:
| Pao2:Fio2 ratio ≤ 300 mm Hg; Paco2 ≤ 45 mm Hg; respiratory rate ≥ 25 beats/min; no history of chronic respiratory failure |
| Group 1: Non-rebreather mask
|
Group 2: NIV
| |||||||
Hernandez et al., 2016 (33) | 7 ICUs in Spain | 527 (62.0) |
| APACHE II:
| Pao2:Fio2 ratio > 150 mm Hg; Paco2 ≤ 45 mm Hg; pH > 7.35 |
| Nasal cannula or non-rebreather mask
|
Maggiore et al., 2014 (21) | 2 ICUs in Italy | 105 (64.8) |
| SAPS II:
| Pao2:Fio2 ratio ≤ 300 mm Hg; Paco2 ≥ 45 mm Hg; respiratory rate ≥ 25 beats/min |
| Venturi mask
|
Perbet et al., 2014 (34)* | 4 ICUs in France | 80 | NA | NA | NA | NA | Conventional oxygen therapy |
Simon et al., 2014 (35) | 1 ICU in Germany | 40 (60.0) |
| SAPS II:
| Pao2:Fio2 ratio < 300 mm Hg |
| NIV
|
Stephan et al., 2015 (32) | 6 ICUs in France | 830 (66.4) |
| SAPS II:
| Pao2:Fio2 ratio ≤ 300 mm Hg; respiratory rate ≥ 25 beats/min |
| BiPAP
|
Note: APACHE II = Acute Physiology and Chronic Health Evaluation II score (range 0 to 71 points, with higher scores indicating more severe disease), BiPAP = bilevel positive airway pressure, HFNC = high-flow nasal cannula oxygen therapy, ICU = intensive care unit, NA = not available, NIV = noninvasive ventilation, Paco2 = partial pressure of arterial carbon dioxide, Pao2:Fio2 = ratio of partial pressure of arterial oxygen to fraction of inspired oxygen, PEEP = positive end-expiratory pressure, PS = pressure support, Sao2 = arterial oxygen saturation, SAPS = Simplified Acute Physiology Score (range 0 to 163 points, with higher scores indicating more severe disease), SD = standard deviation, Spo2 = peripheral capillary oxygen saturation, Vt = tidal volume.
↵* Conference abstract; details about the trial and some outcomes were not available after author contact.